BTG - Articles and news items

BTG receives CE mark certification for radiopaque drug-eluting bead

Industry news / 6 April 2017 / Niamh Marriott, Junior Editor

BTG has received Class III CE Mark certification for DC Bead LUMI, the first commercially available radiopaque drug-eluting bead…

First patient in Singapore treated with BTG’s TheraSphere radioembolization therapy

Industry news / 11 June 2015 / Victoria White

The first patient in Singapore has been treated with TheraSphere radioembolization therapy- a treatment for primary liver cancer and metastatic bowel cancer…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+